CIK: 0001839209 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $2,383,372 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 19,344,621 | $1,924,596 | 80.8% | $68.05 | +12.4% | COM PAR $.01 | 457669307 |
| — | VERONA PHARMA PLC | 4,129,618 | $387,441 | 16.3% | $61.06 | — | SPONSORED ADS | 925050106 |
| — | CIDARA THERAPEUTICS INC | 768,424 | $37,999 | 1.6% | $49.45 | — | COM NEW | 171757206 |
| — | MERUS N V | 395,738 | $20,970 | 0.9% | $52.99 | — | COM | N5749R100 |
| ALLO | ALLOGENE THERAPEUTICS INC | 10,479,791 | $12,366 | 0.5% | $1.89 | -29.5% | COM | 019770106 |